Talk:Ovarian cancer
Jump to navigation
Jump to search
The purpose of this page is to record, in reverse chronological order, conversations about content changes for the accompanying main page.
April 2018
- User:Jwarner: Rucaparib is now FDA approved "for the maintenance treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy." However, ARIEL3 specified that patients had received at least two previous platinum-based chemotherapy regimens, so we will leave the regimen in the current setting (maintenance after second-line chemotherapy for platinum-sensitive disease).